# Cancer Center Support Grant

> **NIH NIH P30** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2021 · $250,000

## Abstract

PROJECT SUMMARY
In this effort, we will analyze clinically-annotated tumor samples from 50 GBM patients at initial
diagnosis and at time of recurrence (50 “pairs”). We will perform single cell transcriptomic
analyses at baseline and at recurrence, integrating cellular, molecular and phenotypic
measurements with detailed clinical annotation, and histological and radiographic
measurements to resolve the critical features that drive tumor evolution and disease
progression. We will achieve this through a consortium of NCI Cancer Centers, and this will
enable us to optimize statistical robustness and capture the extensive heterogeneity of the
disease.

## Key facts

- **NIH application ID:** 10408448
- **Project number:** 3P30CA013696-46S1
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Anil K Rustgi
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $250,000
- **Award type:** 3
- **Project period:** 1997-07-04 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10408448

## Citation

> US National Institutes of Health, RePORTER application 10408448, Cancer Center Support Grant (3P30CA013696-46S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10408448. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*